Johnson & Johnson

Page 15 of 18

Johnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
Health

Johnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%

By
June 5, 2017
Johnson & Johnson Products Ahead Of Earnings
Health

Johnson & Johnson Unveils Ambitious Multi-Billion Dollar Plan

By
May 17, 2017
FDA Approves New Drug That Could Take a Slice Out of Johnson & Johnson’s Best Seller
Health

FDA Approves New Drug That Could Take a Slice Out of Johnson & Johnson’s Best Seller

By
April 24, 2017
Hip Prosthesis, Surgery X-rays
Health

Johnson & Johnson Wants to Use 3D Printing to Heal Broken Bones

By
April 20, 2017
Johnson & Johnson Products Ahead Of Earnings Figures
Tech

Johnson & Johnson Will Also Remove Ads on YouTube

By
March 23, 2017
Johnson & Johnson baby powder.
Health

Johnson & Johnson Just Won One of Its Talc Powder Cancer Lawsuits

By
March 6, 2017
Sandra (Sandi) E. Peterson, Executive Vice President, Group Worldwide Chairman for Johnson and Johnson. At the J&J Global Strategic Design Office, New York, Thursday 19 May 2016.Credit: Timothy Fadek / Redux Pictures
Health

Why You Should Surround Yourself With Great People

By
February 17, 2017
Johnson & Johnson Products Ahead Of Earnings
Finance

How Sanofi Lost Out to J&J in the $30 Billion Battle for Actelion

By
February 16, 2017
Pictured in a photo taken with a tilt an
Finance

Johnson & Johnson’s $30 Billion Cash Deal Is Finally Happening

By Reuters and Michelle Toh
January 26, 2017
Fortune Most Powerful Women Next Gen Summit
Tech

In Win for Tech Industry, Patent Office Head to Stay Under Trump

By
January 19, 2017
World AIDS Day Is Marked Around The World
Health

Why GSK’s Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead

By
December 21, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Decline Amid Data, Disappointing Retailer Results
Health

Johnson & Johnson Just Got Hit With a $1B Verdict Over Faulty Hip Implants

By
December 2, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Decline Amid Data, Disappointing Retailer Results
Finance

Johnson & Johnson Reportedly Wants to Buy This $17 Billion Biotech Firm

By
November 25, 2016
Johnson & Johnson baby powder.
Retail

Johnson & Johnson Hopes to Reverse Baby Powder Lawsuits

By
November 7, 2016
LS010183
Health

Johnson & Johnson Ordered to Pay $70 Million to California Woman For Cancer-Linked Baby Powder

By
October 28, 2016

Most Popular